These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28717974)
1. Improvement of Oral Bioavailability of Lopinavir Without Co-administration of Ritonavir Using Microspheres of Thiolated Xyloglucan. Madgulkar AR; Bhalekar MR; Kadam AA AAPS PharmSciTech; 2018 Jan; 19(1):293-302. PubMed ID: 28717974 [TBL] [Abstract][Full Text] [Related]
2. Improving oral bioavailability of acyclovir using nanoparticulates of thiolated xyloglucan. Madgulkar A; Bhalekar MR; Dikpati AA Int J Biol Macromol; 2016 Aug; 89():689-99. PubMed ID: 27026342 [TBL] [Abstract][Full Text] [Related]
3. Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir. Garg B; Katare OP; Beg S; Lohan S; Singh B Colloids Surf B Biointerfaces; 2016 May; 141():611-622. PubMed ID: 26916320 [TBL] [Abstract][Full Text] [Related]
4. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404 [TBL] [Abstract][Full Text] [Related]
5. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Ansari H; Singh P Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641 [TBL] [Abstract][Full Text] [Related]
6. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation. Ravi PR; Vats R; Dalal V; Murthy AN J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749 [TBL] [Abstract][Full Text] [Related]
7. QbD based development of proliposome of lopinavir for improved oral bioavailability. Patel GM; Shelat PK; Lalwani AN Eur J Pharm Sci; 2017 Oct; 108():50-61. PubMed ID: 27586019 [TBL] [Abstract][Full Text] [Related]
8. Modified pullulan nanoparticles for oral delivery of lopinavir: formulation and pharmacokinetic evaluation. Ravi PR; Vats R; Balija J; Adapa SP; Aditya N Carbohydr Polym; 2014 Sep; 110():320-8. PubMed ID: 24906762 [TBL] [Abstract][Full Text] [Related]
9. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication. Thombre NA; Gide PS Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198 [TBL] [Abstract][Full Text] [Related]
10. Effect of grapefruit juice and ritonavir on pharmacokinetics of lopinavir in Wistar rats. Ravi PR; Vats R; Thakur R; Srivani S; Aditya N Phytother Res; 2012 Oct; 26(10):1490-5. PubMed ID: 22308076 [TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of microspheres of xyloglucan and its thiolated xyloglucan derivative. Sonawane S; Bhalekar M; Shimpi S Int J Biol Macromol; 2014 Aug; 69():499-505. PubMed ID: 24942993 [TBL] [Abstract][Full Text] [Related]
12. Alginate microspheres of isoniazid for oral sustained drug delivery. Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732 [TBL] [Abstract][Full Text] [Related]
13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
14. Re: Acknowledgement of human bioequivalency of matrix's lopinavir-ritonavir formulation to Kaletra, comment to article on Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al. Rackley RJ J Pharm Sci; 2010 Feb; 99(2):568-71; author reply 574. PubMed ID: 19746411 [No Abstract] [Full Text] [Related]
15. Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug. Nassar T; Rohald A; Naraykin N; Barasch D; Amsalem O; Prabhu P; Kotler M; Benita S J Drug Target; 2019; 27(5-6):590-600. PubMed ID: 30470150 [TBL] [Abstract][Full Text] [Related]
16. Optimized administration regimen of lopinavir for a myocardial ischaemia reperfusion study in Sprague-Dawley rats. Katayama M; Jiamsripong P; Bukatina AE; Lombari TR; McMahon EM; Gades NM; Belohlavek M Lab Anim; 2013 Apr; 47(2):122-6. PubMed ID: 23563365 [TBL] [Abstract][Full Text] [Related]
18. Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine. Shinde UA; Shete JN; Nair HA; Singh KH Pharm Dev Technol; 2014 Nov; 19(7):813-23. PubMed ID: 24032373 [TBL] [Abstract][Full Text] [Related]
19. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Patel G; Shelat P; Lalwani A Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model. Garren KW; Rahim S; Marsh K; Morris JB J Pharm Sci; 2010 Feb; 99(2):626-31. PubMed ID: 19230020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]